谷歌浏览器插件
订阅小程序
在清言上使用

First-in-man Study of the PSMA Minibody IR800-IAB2M for Molecularly Targeted Intraoperative Fluorescence Guidance During Radical Prostatectomy

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2024)

引用 0|浏览1
暂无评分
摘要
Prostate-specific membrane antigen (PSMA) is increasingly used to image prostate cancer in clinical practice. We sought to develop and test a humanised PSMA minibody IAB2M conjugated to the fluorophore IRDye 800CW-NHS ester in men undergoing robot-assisted laparoscopic radical prostatectomy (RARP) to image prostate cancer cells during surgery. The minibody was evaluated pre-clinically using PSMA positive/negative xenograft models, following which 23 men undergoing RARP between 2018 and 2020 received between 2.5 mg and 20 mg of IR800-IAB2M intravenously, at intervals between 24 h and 17 days prior to surgery. At every step of the procedure, the prostate, pelvic lymph node chains and extra-prostatic surrounding tissue were imaged with a dual Near-infrared (NIR) and white light optical platform for fluorescence in vivo and ex vivo. Histopathological evaluation of intraoperative and postoperative microscopic fluorescence imaging was undertaken for verification. Twenty-three patients were evaluated to optimise both the dose of the reagent and the interval between injection and surgery and secure the best possible specificity of fluorescence images. Six cases are presented in detail as exemplars. Overall sensitivity and specificity in detecting non-lymph-node extra-prostatic cancer tissue were 100 https://www.isrctn.com/ISRCTN10046036 .
更多
查看译文
关键词
Prostate Cancer,Intraoperative imaging,Fluorescence Molecular Imaging,Optical imaging
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要